[Federal Register Volume 73, Number 155 (Monday, August 11, 2008)]
[Notices]
[Pages 46626-46627]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-18426]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


National Institute for Occupational Safety and Health Advisory 
Board on Radiation and Worker Health

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), and pursuant to the requirements of 42 
CFR 83.15(a), the Centers for Disease Control and Prevention (CDC), 
announces the following meeting of the aforementioned committee:
    Board Meeting Times and Dates:
    (All times are Pacific Daylight Time)
    1 p.m.-5 p.m., September 2, 2008.
    9 a.m.-5 p.m., September 3, 2008.
    9 a.m.-2 p.m., September 4, 2008.
    Public Comment Times and Dates:
    (All times are Pacific Daylight Time)
    5 p.m.-6 p.m., September 2, 2008.
    7:30 p.m.-8:30 p.m., September 3, 2008.
    Place: Crowne Plaza Redondo Beach, 300 N. Harbor Drive, Redondo 
Beach, California 90277, Telephone: (310) 318-7705, Fax: (310) 376-
61930.
    Status: Open to the public, limited only by the space available. 
The meeting space accommodates approximately 75 to 100 people.
    Background: The Advisory Board was established under the Energy 
Employees Occupational Illness Compensation Program Act (EEOICPA) of 
2000 to advise the President on a variety of policy and technical 
functions required to implement and effectively manage the new 
compensation program. The key functions of the Advisory Board include 
providing advice on the development of probability of causation

[[Page 46627]]

guidelines which have been promulgated by the Department of Health and 
Human Services (HHS) as a final rule, advice on methods of dose 
reconstruction which have also been promulgated by HHS as a final rule, 
advice on the scientific validity and quality of dose estimation and 
reconstruction efforts being performed for purposes of the compensation 
program, and advice on petitions to add classes of workers to the 
Special Exposure Cohort.
    In December 2000, the President delegated responsibility for 
funding, staffing, and operating the Advisory Board to HHS, which 
subsequently delegated this authority to the CDC. NIOSH implements this 
responsibility for CDC. The charter was issued on August 3, 2001, 
renewed at appropriate intervals, and will expire on August 3, 2009.
    Purpose: This Advisory Board is charged with (a) providing advice 
to the Secretary, HHS, on the development of guidelines under Executive 
Order 13179; (b) providing advice to the Secretary, HHS, on the 
scientific validity and quality of dose (c) upon request by the 
Secretary, HHS, advising the Secretary on whether there is a class of 
employees at any Department of Energy facility who were exposed to 
radiation but for whom it is not feasible to estimate their radiation 
dose, and on whether there is reasonable likelihood that such radiation 
doses may have endangered the health of members of this class.
    Matters To Be Discussed: The agenda for the Advisory Board meeting 
includes: NIOSH Program Status Update; Special Exposure Cohort (SEC) 
Petitions for: Pantex; Connecticut Aircraft Nuclear Engine Laboratory 
(CANEL); SEC Petition Updates: Chapman Valve; Special Exposure Cohort 
(SEC) Petition Status Update(s); Department of Labor (DOL) Update; 
Department of Energy (DOE) Update; Work Group reports; Subcommittee on 
Dose Reconstruction Reviews Report; and Board Future Plans and 
Schedules.
    The agenda is subject to change as priorities dictate.
    In the event an individual cannot attend, written comments may be 
submitted according the policy provided below. Any written comments 
received will be provided at the meeting and should be submitted to the 
contact person below well in advance of the meeting.
    Policy on Redaction of Board Meeting Transcripts (Public Comment), 
if a person making a comment gives his or her name, no attempt will be 
made to redact that name. NIOSH will take reasonable steps to ensure 
that individuals making public comment are aware of the fact that their 
comments (including their name, if provided) will appear in a 
transcript of the meeting posted on a public Web site. Such reasonable 
steps include: (a) A statement read at the start of each public comment 
period stating that transcripts will be posted and names of speakers 
will not be redacted; (b) A printed copy of the statement mentioned in 
(a) above will be displayed on the table where individuals sign up to 
make public comment; (c) A statement such as outlined in (a) above will 
also appear with the agenda for a Board Meeting when it is posted on 
the NIOSH Web site; (d) A statement such as in (a) above will appear in 
the Federal Register notice that announces Board and Subcommittee 
meetings. If an individual in making a statement reveals personal 
information (e.g., medical information) about themselves that 
information will not usually be redacted. The NIOSH Freedom of 
Information Act coordinator will, however, review such revelations in 
accordance with the Freedom of Information Act and the Federal Advisory 
Committee Act and if deemed appropriate, will redact such information. 
All disclosures of information concerning third parties will be 
redacted. If it comes to the attention of the Designated Federal 
Officer (DFO) that an individual wishes to share information with the 
Board but objects to doing so in a public forum, the DFO will work with 
that individual, in accordance with the Federal Advisory Committee Act, 
to find a way that the Board can hear such comments.
    Contact Person for More Information: Zaida Burgos, Committee 
Management Specialist, NIOSH, CDC, 1600 Clifton Road, Atlanta, Georgia 
30033, Telephone (404) 498-2548 Toll Free: (800) CDC-INFO, E-mail 
<a href="/cdn-cgi/l/email-protection#315e525042715255521f565e47"><span class="__cf_email__" data-cfemail="e8878b899ba88b8c8bc68f879e">[email protected]</span></a>.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both CDC and the Agency for Toxic Substances and Disease Registry.

    Dated: August 4, 2008.
Daniel Riedford,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. E8-18426 Filed 8-8-08; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>